SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-006631
Filing Date
2023-09-22
Accepted
2023-09-22 14:51:11
Documents
59
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cannarx_i10q-033123.htm   iXBRL 10-Q 631090
2 CERTIFICATION cannarx_ex3101.htm EX-31.1 11560
3 CERTIFICATION cannarx_ex3102.htm EX-31.2 11568
4 CERTIFICATION cannarx_ex3200.htm EX-32 4815
  Complete submission text file 0001683168-23-006631.txt   3593272

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cpmd-20230331.xsd EX-101.SCH 32472
6 XBRL CALCULATION FILE cpmd-20230331_cal.xml EX-101.CAL 55597
7 XBRL DEFINITION FILE cpmd-20230331_def.xml EX-101.DEF 111932
8 XBRL LABEL FILE cpmd-20230331_lab.xml EX-101.LAB 239702
9 XBRL PRESENTATION FILE cpmd-20230331_pre.xml EX-101.PRE 202206
53 EXTRACTED XBRL INSTANCE DOCUMENT cannarx_i10q-033123_htm.xml XML 389465
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 231271352
SIC: 2834 Pharmaceutical Preparations